Clearside Biomedical, Inc. CLSD
0.41 USD 0.00 (+0.00%)
At closeOct 28, 2026, 4:00 PM EDT
Day range unavailable
52-week range unavailable
- YTD
- 0.00%
- 1 year
- 0.00%
CLSD revenue history
Revenue is income from the company’s ordinary business activities.
1,664,000 USD
FY 2024 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | 1,664,000 | -6,562,000 | -79.77% |
| FY 2023 | 2023-12-31 | 8,226,000 | 6,899,000 | 519.89% |
| FY 2022 | 2022-12-31 | 1,327,000 | -28,248,000 | -95.51% |
| FY 2021 | 2021-12-31 | 29,575,000 | 21,681,000 | 274.65% |
| FY 2020 | 2020-12-31 | 7,894,000 | 5,721,000 | 263.28% |
| FY 2019 | 2019-12-31 | 2,173,000 | 2,143,000 | 7143.33% |
| FY 2018 | 2018-12-31 | 30,000 | -315,000 | -91.30% |
| FY 2017 | 2017-12-31 | 345,000 | -175,000 | -33.65% |
| FY 2016 | 2016-12-31 | 520,000 | 520,000 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | 0 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-11-20T12:34:23.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.